NCT03161743

Brief Summary

This is a study to determine 1) the consistency of platelet-rich plasma produced by several methods, and 2) whether the platelet content of platelet-rich plasma can be accurately estimated from a baseline CBC platelet count.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 22, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 30, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

August 10, 2017

Status Verified

August 1, 2017

Enrollment Period

11 months

First QC Date

May 18, 2017

Last Update Submit

August 8, 2017

Conditions

Platelet-rich Plasma Production

Keywords

platelet-rich plasmaplatelet

Outcome Measures

Primary Outcomes (2)

  • Platelet yield

    the number of platelets in a PRP sample as a percentage of the number of platelets in the blood from which the PRP was prepared.

    within 8 hours of blood draw

  • Platelet yield estimate accuracy

    standard deviation of the difference between the estimated platelet yield and the actual platelet yield.

    within one month of final data collection

Interventions

venipuncturePROCEDURE

blood draw for the purpose of determining the platelet concentration in PRP

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

normal adults

You may qualify if:

  • English speaking

You may not qualify if:

  • platelet count \< 150,000
  • platelet count \> 350,000
  • History of blood disorder
  • History of altered platelet function
  • History of chemotherapy or radiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Theodore E Harrison

Sidney, British Columbia, V8L5K1, Canada

Location

MeSH Terms

Interventions

Phlebotomy

Intervention Hierarchy (Ancestors)

Blood Specimen CollectionSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Theodore E Harrison

    Theodore Harrison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDIV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2017

First Posted

May 22, 2017

Study Start

June 30, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

August 10, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations

CA(1)